Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02639507 · ClinicalTrials.gov registry record
International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 40
- Enrollment target
NCT02639507: Completed study, sponsored by Mayo Clinic.
NCT02639507 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02639507 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading to swelling of the central retina (macula), and decreased vision. Removing the vitreous gel with vitrectomy surgery is known to decrease the swelling caused by diabetes. Diabetic retinopathy is often treated with laser or injections of medicine in to the eye.
Interventions
- PROCEDURE Vitrectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2015-06 |
| Est. Completion | 2020-03 |
What the finished NCT02639507 record still lists
NCT02639507 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Vitrectomy is the first listed.
NCT02639507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02639507 about?
NCT02639507 is a clinical study titled "International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients". The purpose of this research is to evaluate the effectiveness of vitrectomy for the treatment of diabetic macular edema. Diabetes is known to cause retinal blood vessels to leak, leading to swelling of the central retina (macula), and decreased vision. Removing the vitreous gel with vitrectomy surge...
What is the current status of trial NCT02639507?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2015-06. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02639507?
The interventions under investigation include: Vitrectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02639507?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia